Gerald Villanueva
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Gerald Villanueva has a total of 55 co-authors. Here are the top co-authors by number of shared publications:
- Spiros P. Hiotis
Department of Surgery, The Icahn School of Medicine at Mount Sinai, New York, NY, USA.
2 shared publications - Adam J. Goodman
New York University School of Medicine, New York, NY
1 shared publication - Amit Saxena
Division of Rheumatology New York University New York New York
1 shared publication Amy Rapkiewicz
Department of Pathology, New York University School of Medicine, 462 1st Avenue 4W39, New York, NY 10016, USA
1 shared publicationAnthony Starpoli
1 shared publicationBalazs Halmos
Columbia University Medical Center
1 shared publication
Latest Publications
- 1 October 2017
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 112, S909
Massive Gastrointestinal Hemorrhage From Aortoesophageal Fistula in a Patient With Congenital Double Aortic Arch
- 1 October 2017
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 112, S909
Massive Gastrointestinal Hemorrhage From Aortoesophageal Fistula in a Patient With Congenital Double Aortic Arch
- 1 July 2017
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (7) , 1095-1123.e3
Assessment of Abilities of Gastroenterology Fellows to Provide Information to Patients With Liver Disease
- 1 July 2017
- Published by Elsevier in Clinical Gastroenterology and Hepatology
- Vol. 15 (7) , 1095-1123.e3
Assessment of Abilities of Gastroenterology Fellows to Provide Information to Patients With Liver Disease
- 11 January 2014
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 45 (1) , 108-111
Complete Pathological Response in a Patient with Metastatic Esophageal Cancer Treated with a Regimen of Capecitabine, Oxaliplatin and Docetaxel: A Case Report
- 11 January 2014
- Published by Springer Nature in Journal of Gastrointestinal Cancer
- Vol. 45 (1) , 108-111
Complete Pathological Response in a Patient with Metastatic Esophageal Cancer Treated with a Regimen of Capecitabine, Oxaliplatin and Docetaxel: A Case Report
- 1 October 2013
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 108, S201
Esophageal Cancer Presenting as Headache and Diplopia: Case Report and Brief Literature Review
- 1 October 2013
- Published by Wolters Kluwer Health in American Journal of Gastroenterology
- Vol. 108, S201
Esophageal Cancer Presenting as Headache and Diplopia: Case Report and Brief Literature Review
- Open Access
- 8 June 2012
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 64
Hepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection.
- 8 June 2012
- Published by Springer Nature in BMC Gastroenterology
- Vol. 12 (1) , 64
Open AccessHepatitis B vs. hepatitis C infection on viral hepatitis-associated hepatocellular carcinoma
To determine clinical-pathologic variables in patients with a new diagnosis of hepatocellular carcinoma (HCC) and underlying hepatitis B vs. C infection.
- Open Access
- 9 January 2012
- Published by Wiley in Journal of Digestive Diseases
- Vol. 13 (4) , 214-218
Clinical prognostic variables in young patients (under 40 years) with hepatitis B virus‐associated hepatocellular carcinoma
OBJECTIVE: The aim of this study was to determine the impact of hepatocelluar carcinoma (HCC) screening in chronic hepatitis B patients who did not meet the current screening recommendations. METHODS: Patients who were admitted to Bellevue Hospital Center with HCC were assessed for risk factors, cirrhosis and tumor-specific factors. Eligibility for liver transplantation or resection with favorable outcome was determined by applying Milan criteria. RESULTS: In all 93 patients were diagnosed with hepatitis B virus (HBV)-associated HCC, 18 of whom were under 40 years. Cirrhosis was infrequently associated with HCC in this group, with most cancers occurring in non-cirrhotic patients (12/18, 66.7%). No patient developed HCC outside the American Association for the Study of Liver Diseases (AASLD) cancer screening recommendations (young age, non-cirrhotic) were eligible for liver transplantation or resection with favorable outcomes (within Milan criteria). However, HCC patients who were diagnosed within AASLD screening recommendations did meet Milan criteria in 17.3% (14/81) patients. CONCLUSIONS: Current guidelines for HCC screening in patients with HBV may lead to a delay in diagnosis in non-cirrhotic patients under 40 years. Consideration should be given to modifying current recommendations to advocate entering HBV patients into a cancer-screening program at young age.
- 9 January 2012
- Published by Wiley in Journal of Digestive Diseases
- Vol. 13 (4) , 214-218
Open AccessClinical prognostic variables in young patients (under 40 years) with hepatitis B virus‐associated hepatocellular carcinoma
OBJECTIVE: The aim of this study was to determine the impact of hepatocelluar carcinoma (HCC) screening in chronic hepatitis B patients who did not meet the current screening recommendations. METHODS: Patients who were admitted to Bellevue Hospital Center with HCC were assessed for risk factors, cirrhosis and tumor-specific factors. Eligibility for liver transplantation or resection with favorable outcome was determined by applying Milan criteria. RESULTS: In all 93 patients were diagnosed with hepatitis B virus (HBV)-associated HCC, 18 of whom were under 40 years. Cirrhosis was infrequently associated with HCC in this group, with most cancers occurring in non-cirrhotic patients (12/18, 66.7%). No patient developed HCC outside the American Association for the Study of Liver Diseases (AASLD) cancer screening recommendations (young age, non-cirrhotic) were eligible for liver transplantation or resection with favorable outcomes (within Milan criteria). However, HCC patients who were diagnosed within AASLD screening recommendations did meet Milan criteria in 17.3% (14/81) patients. CONCLUSIONS: Current guidelines for HCC screening in patients with HBV may lead to a delay in diagnosis in non-cirrhotic patients under 40 years. Consideration should be given to modifying current recommendations to advocate entering HBV patients into a cancer-screening program at young age.
- Open Access
- 1 September 2010
- Published by Wiley in HPB Surgery
- Vol. 2010, 1-4
Hepatectomy for Hepatocellular Carcinoma Complicated by Vasculitis Flare
Background. The hepatitis C virus is a major cause of hepatocellular carcinoma. Extrahepatic manifestations of hepatitis C include mixed cryoglobulinemia which can result in ischemic damage to multiple organs. The management of these sequelae in posthepatectomy patients is unclear. Case Report. A 49-year-old male with hepatitis C was found to have a 4 cm hepatocellular carcinoma on surveillance imaging. He underwent portal vein embolization followed by hepatectomy. His postoperative course was complicated by the development of splenic infarcts, small bowel ischemia, skin lesions, and liver damage. Findings of elevated cryocrit and elevated rheumatoid factor suggested the diagnosis of cryoglobulin-related vasculitis. The patient improved on supportive care. Conclusion. Cryoglobulinemia is associated with hepatitis C and may complicate the care of this patient population. The treatment of cryoglobulinemia posthepatectomy patients is complicated by concerns over how medications may affect the regenerating liver. Steroids should be used with caution in this setting. Summary. Brief report of hepatectomy complicated by vasculitis in the context of hepatocellular carcinoma secondary to hepatitis C addresses the management of mixed cryoglobulinemia in post-hepatectomy patients.
- 1 September 2010
- Published by Wiley in HPB Surgery
- Vol. 2010, 1-4
Open AccessHepatectomy for Hepatocellular Carcinoma Complicated by Vasculitis Flare
Background. The hepatitis C virus is a major cause of hepatocellular carcinoma. Extrahepatic manifestations of hepatitis C include mixed cryoglobulinemia which can result in ischemic damage to multiple organs. The management of these sequelae in posthepatectomy patients is unclear. Case Report. A 49-year-old male with hepatitis C was found to have a 4 cm hepatocellular carcinoma on surveillance imaging. He underwent portal vein embolization followed by hepatectomy. His postoperative course was complicated by the development of splenic infarcts, small bowel ischemia, skin lesions, and liver damage. Findings of elevated cryocrit and elevated rheumatoid factor suggested the diagnosis of cryoglobulin-related vasculitis. The patient improved on supportive care. Conclusion. Cryoglobulinemia is associated with hepatitis C and may complicate the care of this patient population. The treatment of cryoglobulinemia posthepatectomy patients is complicated by concerns over how medications may affect the regenerating liver. Steroids should be used with caution in this setting. Summary. Brief report of hepatectomy complicated by vasculitis in the context of hepatocellular carcinoma secondary to hepatitis C addresses the management of mixed cryoglobulinemia in post-hepatectomy patients.
- 1 September 2006
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 64 (3) , 361-368
Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopy
- 1 September 2006
- Published by Elsevier in Gastrointestinal Endoscopy
- Vol. 64 (3) , 361-368
Multicenter, randomized, controlled trial of virtual-reality simulator training in acquisition of competency in colonoscopy